VR Logo

Ajanta Pharma Ltd.


Healthcare | Drugs & Pharma

we think vacations are for wimps

40 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: Manufacture of allopathic pharmaceutical preparations

Incorporated: 1979

Chairman: Mannalal B Agrawal

Managing Director: Yogesh M Agrawal

Group: Vimal Agrawal

Listing: NSE: AJANTPHARM, BSE: 532331

Headquarters: Mumbai, Maharashtra

Website: www.ajantapharma.com

Key Facts

Market cap: R 14,629.35 Cr

Revenue (TTM): R 2,644.13 Cr

Earnings (TTM): R 500.83 Cr

Cash: R 272.39 Cr

Total Debt: R 45.68 Cr

Promoters' ownership: 70.51%

Liquidity: High

52 Week range: R 903.40 - 1,759.95

Face value: R2.00

Shares outstanding: 8,72,61,270

10 Years Aggregate:

  • CFO: 2,939.66 Cr
  • EBITDA: 4,502.29 Cr
  • Net Profit: 3,029.57 Cr

Stock Performance

Time Period Ajanta Pharma S&P BSE Healthcare S&P BSE Mid Cap
YTD76.7746.26-3.66
1 month21.2918.537.64
3 months18.4828.6226.23
1 Year80.2554.375.46
3 Years12.4615.39-0.76
5 Years0.922.334.52
10 Years50.6713.466.63
As on 10-Aug-2020
Year Ajanta Pharma S&P BSE Mid Cap S&P BSE Healthcare
2019-17.53-3.05-3.55
2018-20.40-13.31-5.89
2017-16.3448.130.49
201633.857.97-12.88
201541.197.4315.06
2014145.6154.6947.43
2013269.10-5.7322.55